Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | bmru protein, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0024 | 0.0127 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.0127 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0024 | 0.0127 | 0.5 |
Echinococcus multilocularis | Diacylglycerol kinase zeta | 0.0024 | 0.0127 | 0.0127 |
Brugia malayi | Diacylglycerol kinase protein 2 | 0.0024 | 0.0127 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0024 | 0.0127 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.0127 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Leishmania major | sphingosine kinase A, B, putative | 0.0024 | 0.0127 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0127 | 0.0127 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0127 | 0.0127 |
Echinococcus granulosus | Diacylglycerol kinase zeta | 0.0024 | 0.0127 | 0.0127 |
Onchocerca volvulus | Ceramide kinase 1 homolog | 0.0024 | 0.0127 | 1 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma cruzi | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0024 | 0.0127 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0623 | 1 | 1 |
Brugia malayi | Ceramide kinase | 0.0024 | 0.0127 | 1 |
Echinococcus multilocularis | ceramide kinase | 0.0024 | 0.0127 | 0.0127 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0127 | 1 |
Trichomonas vaginalis | bmru protein, putative | 0.0024 | 0.0127 | 0.5 |
Schistosoma mansoni | diacylglycerol kinase theta | 0.0024 | 0.0127 | 0.0127 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Brugia malayi | Eye-specific diacylglycerol kinase | 0.0024 | 0.0127 | 1 |
Schistosoma mansoni | proteasome subunit alpha 6 (T01 family) | 0.0024 | 0.0127 | 0.0127 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0623 | 1 | 1 |
Echinococcus granulosus | acylglycerol kinase mitochondrial | 0.0024 | 0.0127 | 0.0127 |
Trypanosoma brucei | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0024 | 0.0127 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0024 | 0.0127 | 1 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.0623 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0623 | 1 | 1 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0024 | 0.0127 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0024 | 0.0127 | 0.5 |
Schistosoma mansoni | diacylglycerol kinase zeta iota | 0.0024 | 0.0127 | 0.0127 |
Schistosoma mansoni | sphingosine kinase A B | 0.0623 | 1 | 1 |
Onchocerca volvulus | 0.0024 | 0.0127 | 1 | |
Echinococcus granulosus | ceramide kinase | 0.0024 | 0.0127 | 0.0127 |
Toxoplasma gondii | diacylglycerol kinase accessory domain (presumed) domain-containing protein | 0.0024 | 0.0127 | 0.5 |
Echinococcus multilocularis | acylglycerol kinase, mitochondrial | 0.0024 | 0.0127 | 0.0127 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0024 | 0.0127 | 1 |
Loa Loa (eye worm) | diacylglycerol kinase 2 | 0.0024 | 0.0127 | 0.0127 |
Schistosoma mansoni | diacylglycerol kinase theta | 0.0024 | 0.0127 | 0.0127 |
Trypanosoma brucei | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0024 | 0.0127 | 0.5 |
Loa Loa (eye worm) | eye-specific diacylglycerol kinase | 0.0024 | 0.0127 | 0.0127 |
Toxoplasma gondii | diacylglycerol kinase catalytic domain-containing protein | 0.0024 | 0.0127 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0127 | 0.0127 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0024 | 0.0127 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0127 | 0.5 |
Leishmania major | diacylglycerol kinase-like protein | 0.0024 | 0.0127 | 0.5 |
Loa Loa (eye worm) | ceramide kinase | 0.0024 | 0.0127 | 0.0127 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0127 | 0.0127 |
Leishmania major | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 1 | 1 |
Trypanosoma brucei | Sphingosine kinase | 0.0024 | 0.0127 | 0.5 |
Echinococcus multilocularis | Diacylglycerol kinase theta | 0.0024 | 0.0127 | 0.0127 |
Trichomonas vaginalis | diacylglycerol kinase, epsilon, putative | 0.0024 | 0.0127 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0623 | 1 | 1 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0024 | 0.0127 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0024 | 0.0127 | 0.5 |
Echinococcus granulosus | Diacylglycerol kinase theta | 0.0024 | 0.0127 | 0.0127 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Antifungal activity against Saccharomyces cerevisiae ATCC 9763 by agar dilution method | ChEMBL. | 10543891 | |
Activity (functional) | Antifungal activity against Cryptococcus neoformans ATCC 32264 by agar dilution method | ChEMBL. | 10543891 | |
Activity (functional) | Antifungal activity against Candida albicans ATCC 10231 by agar dilution method | ChEMBL. | 10543891 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.